130 related articles for article (PubMed ID: 9708402)
1. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy.
Andersson J; Fehniger TE; Patterson BK; Pottage J; Agnoli M; Jones P; Behbahani H; Landay A
AIDS; 1998 Jul; 12(11):F123-9. PubMed ID: 9708402
[TBL] [Abstract][Full Text] [Related]
2. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
[TBL] [Abstract][Full Text] [Related]
3. Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy.
Behbahani H; Landay A; Patterson BK; Jones P; Pottage J; Agnoli M; Andersson J; Spetz AL
J Acquir Immune Defic Syndr; 2000 Oct; 25(2):150-6. PubMed ID: 11103045
[TBL] [Abstract][Full Text] [Related]
4. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.
Zanussi S; Simonelli C; Bortolin MT; D'Andrea M; Crepaldi C; Vaccher E; Nasti G; Politi D; Barzan L; Tirelli U; De Paoli P
Clin Exp Immunol; 1999 Jun; 116(3):486-92. PubMed ID: 10361239
[TBL] [Abstract][Full Text] [Related]
5. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
7. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
8. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
[TBL] [Abstract][Full Text] [Related]
9. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
[TBL] [Abstract][Full Text] [Related]
10. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.
Martinon F; Michelet C; Peguillet I; Taoufik Y; Lefebvre P; Goujard C; Guillet JG; Delfraissy JF; Lantz O
AIDS; 1999 Feb; 13(2):185-94. PubMed ID: 10202824
[TBL] [Abstract][Full Text] [Related]
11. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
12. Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy.
Macías J; Japón MA; Leal M; Sáez C; Pineda JA; Segura DI; Ortega J; Lissen E
AIDS; 2001 Dec; 15(18):2371-8. PubMed ID: 11740187
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo.
Audigé A; Schlaepfer E; Bonanomi A; Joller H; Knuchel MC; Weber M; Nadal D; Speck RF
J Immunol; 2004 Feb; 172(4):2687-96. PubMed ID: 14764744
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
[TBL] [Abstract][Full Text] [Related]
15. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
Notermans DW; Jurriaans S; de Wolf F; Foudraine NA; de Jong JJ; Cavert W; Schuwirth CM; Kauffmann RH; Meenhorst PL; McDade H; Goodwin C; Leonard JM; Goudsmit J; Danner SA
AIDS; 1998 Jan; 12(2):167-73. PubMed ID: 9468365
[TBL] [Abstract][Full Text] [Related]
16. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
[TBL] [Abstract][Full Text] [Related]
17. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
[TBL] [Abstract][Full Text] [Related]
18. Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients.
Knuchel MC; Speck RF; Schlaepfer E; Kuster H; Ott P; Günthard HF; Opravil M; Cone RW; Weber R
AIDS; 2000 Dec; 14(17):2661-9. PubMed ID: 11125884
[TBL] [Abstract][Full Text] [Related]
19. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
20. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
